Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately
Globe Newswire•30/09/2026•09:14 ET
0
Key Highlights
- ➤FTC, California, and Utah sued Hims & Hers (HIMS) on July 29, 2026
- ➤Hims & Hers (HIMS) stock fell $4.32, or 14.73%, to $25.00
- ➤FTC alleges Hims & Hers (HIMS) shared health information with Meta, Snap, and others
- ➤FTC alleges near-immediate prescription charges after intake-form submission
- ➤Lead-plaintiff deadline set for November 2, 2026
NEW YORK, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”), a nationally recognized securities litigation law firm, announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 2025,and July 29, 2026 (the "Class Period").
Investors who purchased Hims & Hers shares during the class period and suffered losses may be eligible to participate in the case, with the lead-plaintiff deadline set for November 2, 2026.
Get started
Create a free account to read the full story.